NeuroPace Inc — Director's Dealing 2021

Jun 29, 2021

SEC Form 4/A — Form 4/A

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-06-04

Reporting Person: Favet Michael (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	A	27000	$0.00	Acquired	27000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-04	Stock Option (Right to Buy)	$21.67	A	54000	Acquired	2031-06-03	Common Stock (54000)	Direct

Footnotes

F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

F2: 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.